Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.2200 (-8.42%) ($5.0300 - $6.1500) on Wed. Jul. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.91% (three month average) | RSI | 44 | Latest Price | $5.2200(-8.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.5% a day on average for past five trading days. | Weekly Trend | ANPC declines -5.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) LIT(8%) PCY(8%) IPO(7%) OIH(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.455% in a week (0% probabilities). SHY(-18%) IBB(-9%) XBI(-8%) XLU(-6%) TBT(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.455% (StdDev 4.91%) | Hourly BBV | 0 () | Intraday Trend | -15.1% | | | |
|
Resistance Level | $5.74 | 5 Day Moving Average | $5.55(-5.95%) | 10 Day Moving Average | $5.46(-4.4%) | 20 Day Moving Average | $5.74(-9.06%) | To recent high | -37% | To recent low | 2.6% | Market Cap | $45m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |